 |
|
| Steering Committee |
|
| Sara Tolaney, MD, MPH |
|
| Steering Committee Chair |
|
| Chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, United States |
|
|
| Fatima Cardoso, MD |
|
| Director, Breast Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal |
|
|
| Giuseppe Curigliano, MD, PhD |
|
| Professor, Medical Oncology, Department of Oncology and Hematology-Oncology, University of Milan, Director of the Division of Early Drug Development, European Institute of Oncology (IEO), Milan, Italy |
|
|
| François-Clement Bidard, MD, PhD |
|
| Professor of MedicalOncology, Institut Curie, Université de Versailles, Paris, France |
|
|
| Nicola Fusco, MD |
|
| Director, Division of Pathology, European Institute of Oncology IRCCS, Associate Professor of Pathology, University of Milan, Milan, Italy |
|
|
| Paolo Tarantino, MD, PhD |
|
| Medical Oncologist, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States |
|
|
|
